Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2010
11/17/2010EP2250167A1 Arylmethylidene heterocycles as novel analgesics
11/17/2010EP2250160A1 Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
11/17/2010EP2250155A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
11/17/2010EP2250152A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP2158199B1 Piperidine compounds and uses thereof
11/17/2010EP2021339B1 Rosiglitazone hydrochloride hemihydrate
11/17/2010EP1928861B1 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
11/17/2010EP1899296B1 Histamine-3 receptor antagonists
11/17/2010CN1863784B 2-naphthylimino-1,3-thiazine derivative
11/17/2010CN101889010A Isoxazolo-pyridine derivatives
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101888999A Pyridylmethyl-sulfonamide compounds
11/17/2010CN101885708A 5-polyfluoroalkyl group substituted 2-aminothiazole compound, synthesis method and application thereof
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834035 Allosteric modulators of metabotropic glutamate receptors
11/16/2010US7834030 PPAR agonists; modulate lipid and/or carbohydrate metabolism in mammals; prevention and/or treatment of type-2 diabetes, atherosclerosis, cardiovascular disorders; 3-(2-Chloro-4-{1-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-yl]-ethoxy}-phenyl)-4H-[1,2,4]oxadiazol-5-one
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/16/2010US7834009 treating hepatitis C virus infections; inhibitor of HCV NS5B polymerase; N-{3-[1-(4-Fluoro-benzyl)-4-hydroxy-5-(3-methyl-butyl)-2-oxo-1,2,5,6-tetrahydro-pyridin-3-yl]-1,1-dioxo-1,4-dihydro-1(lambda 6)-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide; coadministering with additional therapeutic agent
11/16/2010US7834007 Calcitonin gene-related peptide (CGRP); migraines; amido- and urea or carbamate functional compounds containing piperidine and one of indazolyl, benzotriazolyl, or benzooxazolin-2-one rings
11/16/2010US7834003 Use as miticide, insecticide, anthelmintic, nematocide; veterinary medicine, pest control; compounds are 1-trisubstituted phenyl-5-(2,3-dioxypropylamino)-4-thio(oxo)-3-substituted pyrazoles
11/16/2010US7834002 4-amino-5-cyanopyrimidine derivatives
11/16/2010US7834000 CGRP receptor antagonists
11/16/2010US7833991 Amine compound and use thereof
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/11/2010WO2010129596A1 Pmk2 modulators for use in the treatment of cancer
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010129451A1 Process for preparing bromo-substituted quinolines
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128156A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127976A1 Isoxazole-pyridine derivatives
11/11/2010WO2010127974A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
11/11/2010WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010WO2010097229A3 Amorphous salt of a macrocyclic inhibitor of hcv
11/11/2010WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor
11/11/2010WO2007143597A9 Organic compounds
11/11/2010US20100286212 Treating and Preventing Viral Infections
11/11/2010US20100286211 Oxazolidinone derivatives as antimicrobials
11/11/2010US20100286210 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/11/2010US20100286201 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine
11/11/2010US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
11/11/2010US20100286181 Pyrrole derivatives with antibacterial activity
11/11/2010US20100286173 Fungicide hydroximoyl-tetrazole derivatives
11/11/2010US20100286170 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
11/11/2010US20100286169 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds
11/11/2010US20100286151 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders
11/11/2010US20100286147 Fungicidal amides
11/11/2010US20100286145 Isophthalamide derivatives inhibiting beta-secretase activity
11/11/2010US20100286135 Heterocyclic amide compounds as protein kinase inhibitors
11/11/2010US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/11/2010US20100286130 Antimicrobial compounds, their synthesis and their use for treatment of mammalian infections
11/11/2010US20100286118 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
11/11/2010US20100286116 Thiazoles
11/11/2010US20100286115 Pyrazoles
11/11/2010US20100286112 Compounds for the treatment of metabolic disorders
11/11/2010US20100286110 Azetidinyl g-protein coupled receptor agonists
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286041 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one
11/11/2010US20100285958 Chiral 2-(benzylsulfinyl)Thiazole derivatives and 2-[(1H-pyrazol-4-ylmethyl)sulfinyl]thiazole derivatives, processes for their preparation and their use as herbicides and plant growth regulators
11/11/2010US20100285605 Neurofibrillary labels
11/11/2010US20100285470 Monomethine dyes
11/11/2010US20100285006 Compositions of Kinase Inhibitors and Their Use for Treatment of Cancer and Other Diseases Related to Kinases
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010CA2760929A1 Pmk2 modulators for use in the treatment of cancer
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760166A1 Isoxazole-pyridine derivatives
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759598A1 Isoxazole-thiazole derivatives as gaba a receptor inverse agonists for use in the treatment of cognitive disorders
11/11/2010CA2759269A1 P38 kinase inhibiting agents
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/11/2010CA2758289A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248423A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP2247584A1 Fused pyridines active as inhibitors of c-met
11/10/2010EP2247579A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
11/10/2010EP1311495B1 Catalytic process for the preparation of thiazole derivatives
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN101883762A Benzothiazoles as ghrelin receptor modulators
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829065 Inhibiting the growth of tumor cells overexpressing MN protein with enzyme inhibitors of carbonic anhydrase (CA 1X) (MN protein); pyridinium derivatives of aromatic heterocyclic sulfonamides; side-effect reduction; antitumor, -carcinogenic, -metastasis agents
11/09/2010CA2530140C Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2453623C 6-aryl-4-aminopicolinates and their use as herbicides
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010126270A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126082A1 Therapeutic agent for motor disorders